| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Chief Operating Officer
1 company
Neervannan Seshadri is a Chief Operating Officer at Tarsus Pharmaceuticals, Inc.. Recent SEC Form 4 filings include 0 buys and 10 sells.
Estimated insider holdings value: $4.8M based on current market prices.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Mar 20, 2025 | TARS Tarsus Pharmaceuticals, Inc. | Chief Operating Officer | Sell | 7,583 | $47.89 | $363,141.50 | -3.0% | -17.7% | +29.3% | |
| Mar 18, 2024 | TARS Tarsus Pharmaceuticals, Inc. | Chief Operating Officer | Sale+OE | 4,879 | $30.60 | $149,297.40 | -7.0% | -5.8% | +50.8% | |
| Mar 23, 2023 | TARS Tarsus Pharmaceuticals, Inc. | Chief Operating Officer | Sell | 1,141 | $12.55 | $14,324.14 | -0.7% | +51.2% | +176.9% | |
| Mar 20, 2023 | TARS Tarsus Pharmaceuticals, Inc. | Chief Operating Officer | Sell | 740 | $12.94 | $9,572.60 | -0.7% | +46.1% | +141.5% | |
| Mar 16, 2023 | TARS Tarsus Pharmaceuticals, Inc. | Chief Operating Officer | Sale+OE | 357 | $13.43 | $4,794.51 | -0.6% | +38.5% | +135.3% |